-+ 0.00%
-+ 0.00%
-+ 0.00%

Keybanc Maintains Overweight on Steris, Lowers Price Target to $269

Benzinga·05/13/2026 12:54:00
Listen to the news
Keybanc analyst Brett Fishbin maintains Steris (NYSE:STE) with a Overweight and lowers the price target from $291 to $269.